7a5/prognostin and use thereof for the diagnostic and therapy of tumors

Details for Australian Patent Application No. 2004259281 (hide)

Owner Charite-UniversitatsMedezin Berlin

Inventors Schlag, Peter Michael; Stein, Ulrike; Schwabe, Holger; Walther, Wolfgang

Agent Pizzeys

Pub. Number AU-B-2004259281

PCT Pub. Number WO2005/010042

Priority 103 32 854.8 18.07.03 DE

Filing date 19 July 2004

Wipo publication date 3 February 2005

Acceptance publication date 20 January 2011

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61P 35/00 (2006.01) Antineoplastic agents

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 39/00 (1970.01) Medicinal preparations containing antigens or antibodies

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2005/010042 Priority application(s): WO2005/010042

20 January 2011 Application Accepted

  Published as AU-B-2004259281

12 May 2011 Alteration of Name

  The name of the applicant has been altered to Charite - Universitaetsmedizin Berlin

26 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259282-C5a receptor antagonists

2004259273